Certara Inc (CERT) - Total Assets
Based on the latest financial reports, Certara Inc (CERT) holds total assets worth $1.56 Billion USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Certara Inc net assets for net asset value and shareholders' equity analysis.
Certara Inc - Total Assets Trend (2018–2025)
This chart illustrates how Certara Inc's total assets have evolved over time, based on quarterly financial data.
Certara Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Certara Inc's total assets of $1.56 Billion consist of 20.2% current assets and 79.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 12.2% |
| Accounts Receivable | $103.53 Million | 6.7% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $447.48 Million | 28.8% |
| Goodwill | $773.31 Million | 49.7% |
Asset Composition Trend (2018–2025)
This chart illustrates how Certara Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see CERT company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Certara Inc's current assets represent 20.2% of total assets in 2025, an increase from 6.6% in 2018.
- Cash Position: Cash and equivalents constituted 12.2% of total assets in 2025, up from 1.1% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 77.0% of total assets, a decrease from 91.0% in 2018.
- Asset Diversification: The largest asset category is goodwill at 49.7% of total assets.
Certara Inc Competitors by Total Assets
Key competitors of Certara Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Longmaster Information Tech
SHE:300288
|
China | CN¥1.33 Billion |
|
Echoiq Ltd
AU:EIQ
|
Australia | AU$17.99 Million |
|
ARTRYA Ltd
AU:AYA
|
Australia | AU$23.68 Million |
|
Pharmx Technologies Ltd
AU:PHX
|
Australia | AU$18.82 Million |
|
Intelicare Holdings Ltd
AU:ICR
|
Australia | AU$1.64 Million |
|
Global Health Ltd
AU:GLH
|
Australia | AU$2.84 Million |
|
Newtopia Inc
V:NEWU
|
Canada | CA$664.83K |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$533.91 Million |
Certara Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.05 | 2.13 | 5.48 |
| Quick Ratio | 2.05 | 2.13 | 5.47 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $161.73 Million | $164.76 Million | $284.19 Million |
Certara Inc - Advanced Valuation Insights
This section examines the relationship between Certara Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.06 |
| Latest Market Cap to Assets Ratio | 0.63 |
| Asset Growth Rate (YoY) | -1.2% |
| Total Assets | $1.56 Billion |
| Market Capitalization | $983.48 Million USD |
Valuation Analysis
Below Book Valuation: The market values Certara Inc's assets below their book value (0.63x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Certara Inc's assets decreased by 1.2% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Certara Inc (2018–2025)
The table below shows the annual total assets of Certara Inc from 2018 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $1.56 Billion | -1.18% |
| 2024-12-31 | $1.58 Billion | +0.77% |
| 2023-12-31 | $1.56 Billion | -0.62% |
| 2022-12-31 | $1.57 Billion | +4.05% |
| 2021-12-31 | $1.51 Billion | +19.09% |
| 2020-12-31 | $1.27 Billion | +22.40% |
| 2019-12-31 | $1.04 Billion | -1.37% |
| 2018-12-31 | $1.05 Billion | -- |
About Certara Inc
Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pha… Read more